Astera Labs (NASDAQ:ALAB) Price Target Raised to $425.00

Astera Labs (NASDAQ:ALAB) had its target price raised by Needham & Company LLC from $260.00 to $425.00 in a report published on Wednesday morning, Marketbeat.com reports. Needham & Company LLC currently has a buy rating on the stock.

ALAB has been the subject of a number of other reports. Morgan Stanley raised their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday. Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Jefferies Financial Group upped their price target on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $325.25.

Astera Labs Stock Performance

Shares of ALAB stock opened at $334.17 on Wednesday. The company has a market cap of $57.98 billion, a P/E ratio of 165.43, a PEG ratio of 3.84 and a beta of 3.84. The stock has a 50 day simple moving average of $360.45 and a two-hundred day simple moving average of $235.27. Astera Labs has a fifty-two week low of $97.89 and a fifty-two week high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the business earned $0.44 EPS. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts predict that Astera Labs will post 1.86 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 14,076 shares of Astera Labs stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the completion of the transaction, the general counsel owned 104,139 shares in the company, valued at approximately $24,137,337.42. The trade was a 11.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,244,395 shares of company stock worth $358,865,571. 10.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Astera Labs

Several institutional investors have recently made changes to their positions in ALAB. Bell Investment Advisors Inc purchased a new position in Astera Labs during the second quarter worth about $43,000. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter worth approximately $25,000. Trifecta Capital Advisors LLC bought a new position in shares of Astera Labs in the second quarter valued at approximately $79,000. CX Institutional lifted its holdings in Astera Labs by 1,330.8% during the second quarter. CX Institutional now owns 186 shares of the company’s stock worth $90,000 after acquiring an additional 173 shares during the period. Finally, Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares during the period. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.